yes and that’s exactly why the announcement is premature. If on review of the final data they find for example these patients were on other treatments that could have accounted for all this, do you reckon they’ll put out an announcement saying they might have got it a bit wrong? The reality is - which even Nox fans have to acknowledge- the drug could have done absolutely nothing meaningful in Covid
Ann: Veyonda Showing Potential to Prevent Cytokine Storm, page-28
-
- There are more pages in this discussion • 15 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NOX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
12.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $35.06M | |||
| Open | High | Low | Value | Volume |
| 12.0¢ | 12.0¢ | 11.5¢ | $5.653K | 48.83K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 22101 | 11.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 12.0¢ | 159073 | 5 |
View Market Depth
| Last trade - 16.10pm 18/10/2024 (20 minute delay) ? |
| NOX (ASX) Chart |